Troglitazone Suppresses Cell Growth of Myeloid Leukemia Cell Lines by Induction of p21WAF1/CIP1 Cyclin-Dependent Kinase Inhibitor

This publication has 18 references indexed in Scilit:

• PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
  Cell, 1998
• Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb
  Nature, 1998
• The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
  Nature, 1998
• Glucocorticoid Inhibition of Fibroblast Proliferation and Regulation of the Cyclin Kinase Inhibitor p21Cip1
  Molecular Endocrinology, 1997
• Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes.
  Endocrinology, 1996
• Thiazolidinediones and Fatty Acids Convert Myogenic Cells into Adipose-like Cells
  Published by Elsevier ,1995
• Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
  New England Journal of Medicine, 1994
• Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells
  American Journal of Physiology-Cell Physiology, 1993
• Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM Subjects
  Diabetes Care, 1992
• Ciglitazone, a New Hypoglycemic Agent: I. Studies in ob/ob and db/db Mice, Diabetic Chinese Hamsters, and Normal and Streptozotocin-Diabetic Rats
  Diabetes, 1983